Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

News Releases

Date Title and Summary
Toggle Summary electroCore Announces Second Quarter 2019 Financial Results
Sequential growth reported in paid months of therapy, prescribing physicians and prescriptions dispensed Company to host conference call and webcast today, August 13 , at 4:30pm ET BASKING RIDGE, N.J. , Aug. 13, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc.
Toggle Summary electroCore Announces Distribution Agreement with Doctor’s Medical LLC to Expand Patient Access to gammaCore
BASKING RIDGE, N.J. , Aug. 12, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the company has entered into an exclusive contract with Doctor’s Medical, LLC for distribution rights to gammaCore for patients with workers’
Toggle Summary electroCore to Announce Second Quarter 2019 Financial Results on Tuesday, August 13
Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J. , Aug. 06, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second quarter and six-months ended June 30, 2019
Toggle Summary electroCore Files Registration Statement on Form S-3
BASKING RIDGE, N.J. , July 15, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has filed a "universal shelf" registration statement on Form S-3 (the “Registration Statement”) with the Securities and Exchange
Toggle Summary Multiple Abstracts Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) to be Presented at the American Headache Society’s 61st Annual Scientific Meeting
BASKING RIDGE, N.J. , July 10, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a global commercial-stage bioelectronic medicine company, today announced data presentations focused on non-invasive vagus nerve stimulation (nVNS) to be presented at the American Headache Society’s 61 st
Toggle Summary NICE Issues Draft Guidance on the Use of gammaCore for Cluster Headache
The National Institute for Health and Care Excellence (NICE) draft guidance recommends the use of gammaCore for cluster headache in the National Health Service (NHS) LONDON and BASKING RIDGE, N.J. , July 09, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a global commercial-stage
Toggle Summary electroCore Announces gammaCore(TM) Listing on the NHS Supply Chain Catalogue
LONDON , and BASKING RIDGE, N.J. , June 24, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc.  (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore TM , the company’s non-invasive vagus nerve stimulator (nVNS), will appear on the NHS Supply
Toggle Summary electroCore Announces Frank R. Amato to Step Down as Chief Executive Officer
BASKING RIDGE, N.J. , June 10, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Frank R. Amato will be stepping down as Chief Executive Officer. Mr. Amato joined electroCore in 2012 and was named Chief Executive
Toggle Summary electroCore Announces Comprehensive Redeployment and Cost Reduction Plan
Management to host conference call and webcast at 8:30am ET on Thursday, May 30 BASKING RIDGE, N.J. , May 29, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management and the Board of Directors are making
Toggle Summary electroCore Announces First Quarter 2019 Financial Results
Continues to deliver sequential growth in covered lives, prescribing physicians and FSS facilities  Company to host conference call and webcast today, May 14 , at 4:30pm ET BASKING RIDGE, N.J. , May 14, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic